Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.6 USD | +1.14% | +2.04% | +5.10% |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.10% | 285B | |
+26.10% | 681B | |
+21.14% | 556B | |
-5.23% | 361B | |
+17.00% | 325B | |
+13.72% | 235B | |
+4.02% | 199B | |
-11.45% | 189B | |
-3.98% | 157B | |
+9.17% | 149B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Phase 2 Trial of Lutikizumab Shows Higher Response Rates